A federal lawsuit is targeting a new Oklahoma law that puts conditions on how much drug manufacturers can charge when selling ...

Two of the world's largest pharmaceutical companies are suing Oklahoma to stop a new state law dealing with a $70 billion ...

A federal judge ruled that the government did not violate the law in a dispute with J&J over the 340B drug discount program.

Oklahoma lawmakers passed HB 2048 to protect the 340B Drug Pricing Program, overriding a veto amid growing pressure from pharmaceutical interests.

A federal court denied Johnson & Johnson's motion to implement a 340B drug rebate model, siding with HHS and hospitals who ...

The U.S. District Court for the Middle District of Tennessee June 30 denied a motion for a preliminary injunction by AbbVie in its lawsuit against the state’s law on 340B pricing for contract pharmacy ...

Moderna disclosed that a study of 56,000 volunteers older than 50 found its new mRNA flu vaccine was more effective than an ...

AbbVie Inc. and other drug makers lost a bid to block a Tennessee law regulating contracts between pharmaceutical companies ...

The American Hospital Association and three other healthcare organizations have filed an amicus brief defending Tennessee’s 340B contract pharmacy law, which is facing a challenge from the ...

Johnson & Johnson failed to convince a federal judge that the US government acted unlawfully when it rejected the company’s ...

A U.S. District Court for the District of Columbia judge June 27 ruled against Johnson & Johnson and sided with the ...